Cleared Traditional

K102073 - MED-RX TRANSFER SET

K102073 is an FDA 510(k) clearance for MED-RX TRANSFER SET, manufactured by Benlan, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K102073 · Benlan, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2010
Decision
108d
Days
Class 2
Risk

K102073 is an FDA 510(k) clearance for the MED-RX TRANSFER SET, MODELS 10-1227TS, 10-1300TS, 10-1305TS AND 10-1306TS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Benlan, Inc. (Crofton, US). The FDA issued a Cleared decision on November 8, 2010 after a review of 108 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Benlan, Inc. devices

FDA 510(k) Submission Details - K102073

510(k) Number K102073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2010
Decision Date November 08, 2010
Days to Decision 108 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 129d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K102073.
HOSPIRA PLUM INFUSION SET
K103224 · Hospira, Inc. · Jan 2011
HIGH PRESSURE SETS-400 PSI
K100576 · Icu Medical, Inc. · Dec 2010
INFUSION SETS
K103344 · Hospira, Inc. · Dec 2010
AMSINO I.V. ADMINISTRATION AND EXTENSION SETS
K101958 · Amsino International, Inc. · Sep 2010
ACCU-CHEK ULTRFLEX INFUSION SET
K101196 · Roche Diagnostics Corp. · Aug 2010
HOSPIRA INFUSION BLOOD SETS
K101677 · Hospira, Inc. · Aug 2010